Regulations.gov document
Guidance for Industry Revised Preventive Measures to Reduce the Possible Risk of…
Other · FDA-1997-D-0008 · posted May 27, 2010
Key facts
| Document ID | FDA-1997-D-0008-0007 |
|---|---|
| Title | Guidance for Industry Revised Preventive Measures to Reduce the Possible Risk of Transmission of Creutzfeldt-Jakob Disease (CJD) and Variant Creutzfeldt-Jakob Disease (vCJD) by Blood and Blood Products - [Refences 1-35] |
| Document type | Other |
| Subtype | GDL-Guidance (Supporting and Related Materials) |
| Agency | FDA |
| Docket | FDA-1997-D-0008 |
| Posted | May 27, 2010 |
| Comment period opens | May 27, 2010 |
At a glance
- 1–9 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: